Ram Waisbourd - 16 Aug 2021 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Operating Officer and Chief Business Officer
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Ram Waisbourd
Issuer symbol
ETNB
Transactions as of
16 Aug 2021
Net transactions value
-$114,450
Form type
4
Filing time
18 Aug 2021, 16:10:20 UTC
Previous filing
19 Jul 2021
Next filing
20 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Options Exercise $13,510 +7,000 $1.93* 7,000 16 Aug 2021 Direct
transaction ETNB Common Stock Sale $127,960 -7,000 -100% $18.28 0 16 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Options Exercise $0 -7,000 -18% $0.000000 32,203 16 Aug 2021 Common Stock 7,000 $1.93 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $18.17 to $18.55. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This option represents a right to purchase a total of 102,203 shares of the Issuer's common stock, one quarter of which vested on May 1, 2019, with the remaining three quarters vesting in equal quarterly installments over the following three years.

Remarks:

Chief Operating Officer and Chief Business Officer